[Drug therapy affecting thrombelastographic parameters in infectious hepatitis in children].
D000293:Adolescent; D001663:Bilirubin / Q000097:blood; D001778:Blood Coagulation Disorders / Q000175:diagnosis*; D002648:Child; D002675:Child, Preschool; D005167:Factor VII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006506:Hepatitis A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008710:Methenolone / Q000627:therapeutic use*; D011516:Prothrombin / Q000032:analysis; D013916:Thrombelastography; D005719:gamma-Globulins / Q000627:therapeutic use*
D005719:gamma-Globulins; D005167:Factor VII; D011516:Prothrombin; D005340:Fibrinogen; D008710:Methenolone; D001663:Bilirubin
Uber medikamentöse Beeinflussung thrombelastographischer Parameter bei Hepatitis infectiosa des Kindes.